Blog: MGMA chief says new Part B program will 'kill smaller practices'

Modern Healthcare: The chief advocate for America's medical group administrators says the Obama administration's plans to overhaul Part B drug payments will devastate smaller specialty practices.

Medicare now pays 6% on top of the average sales price of drugs administered by infusion or injection in outpatient settings. That incentivizes providers to choose more expensive medications. The mandatory program beginning in late 2016 would test how prescribing patterns are affected by reducing the bonus to 2.5% and substituting a flat payment of $16.80 per drug per day.

Read article